Pearl Analysis: $58M Raised
What is Pearl?
Pearl offers FDA-cleared AI solutions for dental radiology, enabling real-time analysis of 2D and 3D x-rays. Their technology detects pathologic, restorative, and anatomical features with clinical accuracy. The platform is cleared for use in over 120 countries, including for patients as young as four years old.
Location
West Hollywood, United States
Employees
201-500
Founded
2019
Latest Funding Round Size
Series B
Public Company Status
Private
Recent Funding Round
Series B
Recent Venture Round Amount
$58,000,000
State of Headquarters
California
Product Features & Capabilities
- Second Opinion AI platform for real-time radiologic analysis
- Practice Intelligence for dental practice management
- Precheck for AI-powered insurance verification
- Calibrate for clinical assessment
- FDA-cleared for 2D and 3D x-ray analysis in 100+ countries
Use Cases
Detect periapical radiolucency in 3D x-rays in real time; Identify open margins and root canals in patient images; Automate insurance verification for patient visits; Provide clinical assessment with AI-powered margin detection; Support patient care for children as young as 4 years old
How much Pearl raised
Series B - $58 million
July 24, 2024Lead Investor: Left Lane Capital, Smash Capital, Alpha Partners, Craft Ventures, Neotribe Ventures
Other Considerations
Raised $58M Series B in 2024; FDA-cleared for real-time analysis of 2D and 3D x-rays in 100+ countries; Clearances in 120+ countries including US, EU, and Asia; Trusted by dental practices on Fortune 100; Recognized as the only dental AI with clearance for patients under 5 years old
See something that needs updating? Suggest edits to this profile.